By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AB Science 

3, Avenue George V

Paris    75008  France
Phone: 33-(0)1-47200014 Fax: 33-(0)1-47202411


SEARCH JOBS


Industry
Pharmaceutical






Company News
AB Science (AB.PA): Report Of Positive Clinical Study Data In Metastatic Colorectal Cancer 12/19/2014 7:39:56 AM
AB Science (AB.PA): Web Conference On Masitinib In Asthma - Safety And Efficacy Update 12/1/2014 4:18:42 PM
AB Science (AB.PA) Advances Ultra-Selective SYK Kinase Inhibitor Into Full Preclinical Development 12/1/2014 10:36:10 AM
AB Science (AB.PA): The Data And Safety Monitoring Board Recommends The Continuation Of The Phase 2 Study With Masitinib In Advanced Hepatocellular Carcinoma 11/12/2014 10:30:17 AM
AB Science (AB.PA): Masitinib In Mastocytosis - Summary Of Web Conference 11/10/2014 10:01:22 AM
AB Science (AB.PA): Web Conference On Masitinib In Mastocytosis 11/3/2014 8:28:41 AM
AB Science (AB.PA): Publication Of Preclinical Data On The Neuroprotective Effect Of Masitinib 10/31/2014 7:23:56 AM
AB Science (AB.PA): Initiation Of A New Phase 3 Study With Masitinib In Prostate Cancer, Following Encouraging Survival Results Obtained In A Phase 2 Study 2/21/2014 8:51:42 AM
AB Science (AB.PA): Initiation Of A New Phase 3 Study With Masitinib In Prostate Cancer, Following Encouraging Survival Results Obtained In A Phase 2 Study 2/20/2014 8:58:25 AM
AB Science (AB.PA) Announces Initiation Of A New Phase 3 Study In Oncology With Masitinib In Patients With Metastatic Colorectal Cancer 12/3/2013 9:46:01 AM
1234
//-->